Category: Renal
United Kingdom Renal
-
2024 United Kingdom Chronic Kidney Disease (Ckd) Market Forecast (2025-2030 Outlook)-Market Opportunities Report
... within the NAICS Healthcare industry. The market is expected to increase from USD xx billion in 2025 to USD xx billion by 2030, at a CAGR of xx% from 2025 to 2030. Estimates on product ... Read More
-
2024 United Kingdom Acute Kidney Injury Treatment Forecast (2025-2030 Outlook)-Market Opportunities Report
... the NAICS Healthcare industry. The market is expected to increase from USD xx billion in 2025 to USD xx billion by 2030, at a CAGR of xx% from 2025 to 2030. Estimates on product and ... Read More
-
Antibody Drug Conjugate Market by Target Disease Indication (Breast Cancer, B-cell Lymphoma, Lung Cancer, Multiple Myeloma, Acute Lymphoblastic Leukemia, Gastric Cancer, Renal Cancer, Cervical Cancer and Other Target Disease Indications), Therapeutic Area (Hematological Cancer and Solid Tumor), Linker (Valine-Citrulline, Succinimidyl-4-(N-Maleimidomethyl) Cyclohexane-1-Carboxylate, Tetrapeptide-based Linker, Maleimide, Maleimidocaproyl, Valine-Alanine, Hydrazone (4-(4-Acetylphenoxy) Butanoic Acid (AcBut) and Other Linkers), Payload (Monomethyl Auristatin E, DM1, Duocarmycin, SN-38 / Irinotecan, Monomethyl Auristatin F, SG3199, Ozogamicin, DM4 and Other Payloads), Target Antigens (HER-2 (ERBB2), CD79b, Trop-2, BCMA (TNFRSF17 / BCM), CD19, CD22, Tissue Factor, CD30, CEACAM5, Nectin 4 and Others) And Key Geographical Regions (North America (US, Canada), Europe (Germany, UK, France, Italy, Spain), and Asia-Pacific (China, Australia, Japan)): Industry Trends and Global Forecasts, Till 2035
... Solid Tumor), Linker (Valine-Citrulline, Succinimidyl-4-(N-Maleimidomethyl) Cyclohexane-1-Carboxylate, Tetrapeptide-based Linker, Maleimide, Maleimidocaproyl, Valine-Alanine, Hydrazone (4-(4-Acetylphenoxy) Butanoic Acid (AcBut) and Other Linkers), Payload (Monomethyl Auristatin E, DM1, Duocarmycin, SN-38 / Irinotecan, Monomethyl Auristatin F, SG3199, Ozogamicin, DM4 and ... Read More
-
Europe SGLT2 Inhibitors Market Share, Size, Trends, Industry Analysis Report: By Indication [Cardiovascular, Chronic Kidney Disease (CKD), Type 2 Diabetes, and Others], Drug, Distribution Channel, and Country (Germany, France, UK, Italy, Spain, Netherlands, Russia, and Rest of Europe) – Market Forecast, 2024–2032
... Rest of Europe) – Market Forecast, 2024–2032 The Europe SGLT2 inhibitors market size is expected to reach USD 7,629.79 million by 2032, according to a new study by Polaris Market Research. The report “Europe SGLT2 ... Read More
-
United Kingdom (UK) Nephrology and Urology Procedures Count by Segments (Renal Dialysis Procedures, Nephrolithiasis Procedures and Urinary Tract Stenting Procedures) and Forecast to 2030
... is a comprehensive databook report, covering key procedures data on the United Kingdom Nephrology and Urology Procedures. The databook report provides procedure volumes within segments - Renal Dialysis Procedures, Nephrolithiasis Procedures and Urinary Tract Stenting ... Read More
-
United Kingdom (UK) Renal Dialysis Procedures Count by Segments (Number of Hemodialysis Procedures and Number of Peritoneal Dialysis Procedures) and Forecast to 2030
... comprehensive databook report, covering key procedures data on the United Kingdom Renal Dialysis Procedures. The databook report provides procedure volumes within segments - Number of Hemodialysis Procedures and Number of Peritoneal Dialysis Procedures The United ... Read More
Research Assistance
